Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Operating Leases: 2024-2025

Historic Operating Leases for Upstream Bio (UPB) over the last 1 years, with Sep 2025 value amounting to $703,000.

  • Upstream Bio's Operating Leases fell 44.34% to $703,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $703,000, marking a year-over-year decrease of 44.34%. This contributed to the annual value of $1.1 million for FY2024, which is N/A change from last year.
  • Upstream Bio's Operating Leases amounted to $703,000 in Q3 2025, which was down 17.20% from $849,000 recorded in Q2 2025.
  • In the past 5 years, Upstream Bio's Operating Leases registered a high of $1.3 million during Q3 2024, and its lowest value of $703,000 during Q3 2025.
  • In the last 2 years, Upstream Bio's Operating Leases had a median value of $992,000 in 2025 and averaged $987,400.
  • Data for Upstream Bio's Operating Leases shows a maximum YoY crashed of 44.34% (in 2025) over the last 5 years.
  • Over the past 2 years, Upstream Bio's Operating Leases (Quarterly) stood at $1.1 million in 2024, then slumped by 44.34% to $703,000 in 2025.
  • Its Operating Leases stands at $703,000 for Q3 2025, versus $849,000 for Q2 2025 and $992,000 for Q1 2025.